In contrast, in cross-sectional Mendelian randomization studies, genetically elevated serum concentrations of BNP or the N-terminal fragment of proBNP (NT-proBNP) have been shown to associate with a reduced risk of hypertension [2,3]. The gene discussed is NPPB; the disease is hypertensive disorder.